Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 2
2008 1
2010 2
2011 2
2012 1
2013 1
2014 4
2015 5
2016 1
2017 2
2018 1
2019 1
2020 2
2021 1
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity.
Moral JA, Leung J, Rojas LA, Ruan J, Zhao J, Sethna Z, Ramnarain A, Gasmi B, Gururajan M, Redmond D, Askan G, Bhanot U, Elyada E, Park Y, Tuveson DA, Gönen M, Leach SD, Wolchok JD, DeMatteo RP, Merghoub T, Balachandran VP. Moral JA, et al. Among authors: gururajan m. Nature. 2020 Mar;579(7797):130-135. doi: 10.1038/s41586-020-2015-4. Epub 2020 Feb 19. Nature. 2020. PMID: 32076273 Free PMC article.
microRNAs and Prostate Cancer.
Josson S, Chung LW, Gururajan M. Josson S, et al. Among authors: gururajan m. Adv Exp Med Biol. 2015;889:105-18. doi: 10.1007/978-3-319-23730-5_7. Adv Exp Med Biol. 2015. PMID: 26658999 Free PMC article.
miRNA Characterization from the Extracellular Vesicles.
Josson S, Gururajan M, W K Chung L. Josson S, et al. Among authors: gururajan m. Bio Protoc. 2017 Feb 20;7(4):e2139. doi: 10.21769/BioProtoc.2139. eCollection 2017 Feb 20. Bio Protoc. 2017. PMID: 34458459 Free PMC article.
Substituted diaryl ether compounds as retinoic acid-related orphan Receptor-γt (RORγt) agonists.
Ruan Z, Park PK, Wei D, Purandare A, Wan H, O'Malley D, Stachura S, Perez H, Cavallaro CL, Weigelt CA, Sack JS, Ruzanov M, Khan J, Gururajan M, Wong JJ, Huang Y, Yarde M, Li Z, Chen C, Sun H, Borowski V, Xie JH, Anthony M, Agler M, Fink BE, Harikrishnan LS. Ruan Z, et al. Among authors: gururajan m. Bioorg Med Chem Lett. 2021 Mar 1;35:127778. doi: 10.1016/j.bmcl.2021.127778. Epub 2021 Jan 8. Bioorg Med Chem Lett. 2021. PMID: 33422603
Targeting the tumor-stromal-immune cell axis.
Gururajan M, Josson S, Chung LW. Gururajan M, et al. Oncoscience. 2015 Aug 11;2(9):743-4. doi: 10.18632/oncoscience.190. eCollection 2015. Oncoscience. 2015. PMID: 26501076 Free PMC article. No abstract available.
Inhibition of β2-microglobulin/hemochromatosis enhances radiation sensitivity by induction of iron overload in prostate cancer cells.
Josson S, Matsuoka Y, Gururajan M, Nomura T, Huang WC, Yang X, Lin JT, Bridgman R, Chu CY, Johnstone PA, Zayzafoon M, Hu P, Zhau H, Berel D, Rogatko A, Chung LW. Josson S, et al. Among authors: gururajan m. PLoS One. 2013 Jul 10;8(7):e68366. doi: 10.1371/journal.pone.0068366. Print 2013. PLoS One. 2013. PMID: 23874600 Free PMC article.
Substituted benzyloxytricyclic compounds as retinoic acid-related orphan receptor gamma t (RORγt) agonists.
Harikrishnan LS, Gill P, Kamau MG, Qin LY, Ruan Z, O'Malley D, Huynh T, Stachura S, Cavallaro CL, Lu Z, J-W Duan J, Weigelt CA, Sack JS, Ruzanov M, Khan J, Gururajan M, Wong JJ, Huang Y, Yarde M, Li Z, Chen C, Sun H, Borowski V, Murtaza A, Fink BE. Harikrishnan LS, et al. Among authors: gururajan m. Bioorg Med Chem Lett. 2020 Jun 15;30(12):127204. doi: 10.1016/j.bmcl.2020.127204. Epub 2020 Apr 20. Bioorg Med Chem Lett. 2020. PMID: 32334911
Future perspectives of prostate cancer therapy.
Gururajan M, Posadas EM, Chung LW. Gururajan M, et al. Transl Androl Urol. 2012 Jan 3;1(1):19-32. doi: 10.3978/j.issn.2223-4683.2012.01.03. Transl Androl Urol. 2012. PMID: 22773967 Free PMC article.
In situ Hybridization (ISH) and Quantum Dots (QD) of miRNAs.
Josson S, Gururajan M, W K Chung L. Josson S, et al. Among authors: gururajan m. Bio Protoc. 2017 Feb 20;7(4):e2138. doi: 10.21769/BioProtoc.2138. eCollection 2017 Feb 20. Bio Protoc. 2017. PMID: 34458458 Free PMC article.
28 results